Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physical Activity for Neurogenesis in Diabetic Neuropathy
NCT06101368Unknown
- Sponsor
- NACDS Foundation
- Start
- Jan 2024
- Primary completion
- Dec 2024
01
Overview
Randomised, single-blind trial (2 arms), sponsored by NACDS Foundation. Primary endpoints: Brain Derived Neurotrophic Factor at 12 weeks, Nerve Growth Factor at 12 weeks and 6 more. Status: unknown.
Beyond the preview
Go deeper on NCT06101368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06101368.